Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leuk Lymphoma. 2024 Jan; 65(1):69-77.
View in:
PubMed
subject areas
Consolidation Chemotherapy
Cytarabine
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute
Neoplasm, Residual
Prognosis
Remission Induction
Retrospective Studies
authors with profiles
Anand Patel